Committed to improving
the lives of dialysis patients

Rockwell Medical (Nasdaq: RMTI) is a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney.

About Rockwell Medical

Rockwell Medical is an innovative leader in producing and delivering a portfolio of hemodialysis products, including concentrates (solutions and powders) and related ancillaries, to dialysis providers in the United States and internationally. Rockwell is the second largest supplier of acid and bicarbonate concentrates for dialysis patients in the United States. The Company is dedicated to providing the hemodialysis community with the highest quality products supported by the most reliable delivery service in the industry.

Learn more

Our Platform Technology

Ferric Pyrophosphate Citrate (FPC)

Our innovative therapeutic was developed to replace iron loss in patients with anemia in an entirely different way. Our unique and differentiated molecule, Ferric Pyrophosphate Citrate (FPC), provides a novel mechanism of action with a physiologic approach. FPC donates iron directly to circulating transferrin making it immediately bioavailable for critical body processes, which allows the body to use the iron in a physiologic manner.

Ferric Pyrophosphate Citrate in blood

FPC is introduced to the blood

FPC for iron deficiency

FPC donates iron directly and completely to transferrin – providing bioavailable iron for red blood cell production

avoids iron sequestration

FPC avoids iron sequestration by macrophages in liver and spleen

hemoglobin formation

Transferrin-bound iron immediately delivered to bone marrow for hemoglobin formation

FPC for maintaining hemoglobin

FPC delivers 100% bioavailable iron to maintain hemoglobin

Ferric Pyrophosphate Citrate in blood

FPC is introduced to the blood

arrow
FPC for iron deficiency

FPC donates iron directly and completely to transferrin – providing bioavailable iron for for red blood cell production

arrow
avoids iron sequestration

FPC avoids iron sequestration by macrophages in liver and spleen

arrow
hemoglobin formation

Transferrin-bound iron immediately delivered to bone marrow for hemoglobin formation

arrow
FPC for maintaining hemoglobin

FPC delivers the desired amount of iron maintenance over time

Latest News

arrow left
arrow right

November 14, 2022

Rockwell Medical Provides Business Strategy Update and Announces Third Quarter 2022 Financial and Operational Results

Rockwell is restructuring its business in the short-term to drive revenue and expansion opportunities in the growing hemodialysis market and through international pharmaceutical sales By making this strategic shift, Rockwell expects to achieve profitability in 2024, strengthen its overall financial

Read more

November 9, 2022

Rockwell Medical Reacquires Distribution Rights for its Hemodialysis Concentrates Business from Baxter

Expects to be Profitable in 2024 WIXOM, Mich. --(BUSINESS WIRE)--Nov. 9, 2022-- Rockwell Medical, Inc. (“Rockwell” or the “Company”) (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with

Read more

October 17, 2022

Rockwell Medical to Release Third Quarter 2022 Financial Results on Monday, November 14

WIXOM, Mich. --(BUSINESS WIRE)--Oct. 17, 2022-- Rockwell Medical, Inc. (Nasdaq:RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today announced that it will release its financial

Read more

September 14, 2022

Rockwell Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

WIXOM, Mich. --(BUSINESS WIRE)--Sep. 14, 2022-- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today

Read more

September 7, 2022

Rockwell Medical Names Heather Hunter SVP, Chief Corporate Affairs Officer

WIXOM, Mich. --(BUSINESS WIRE)--Sep. 7, 2022-- Rockwell Medical, Inc. (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today announced that Heather Hunter has joined the

Read more